Beyond Conventional Pharmacotherapy: Unraveling Mechanisms and Advancing Multi-Target Strategies in Alzheimer’s Disease
Pharmaceuticals · 25.11.2025 · 18 (12) · 1797
DOI: 10.3390/ph18121797 ↗Kurz gefasst
Editorial in der Zeitschrift Pharmaceuticals, online erschienen am 25.11.2025. Verfasst von Gabriela-Dumitrita Stanciu. Beteiligte Einrichtung: Advanced Research and Development Center for Experimental Medicine "Prof. Ostin C. Mungiu"-CEMEX, Grigore T. Popa University of Medicine and Pharmacy…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) remains the most prevalent form of dementia worldwide, representing a major and escalating global health burden [...]
Autor:innen und Institutionen
- Advanced Research and Development Center for Experimental Medicine "Prof. Ostin C. Mungiu"-CEMEX, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
ORCID-Profile: Gabriela-Dumitrita Stanciu
Zitieren
APA
Stanciu, G. D. (2025). Beyond Conventional Pharmacotherapy: Unraveling Mechanisms and Advancing Multi-Target Strategies in Alzheimer’s Disease. Pharmaceuticals, 18(12), 1797. https://doi.org/10.3390/ph18121797
Vancouver
Stanciu GD. Beyond Conventional Pharmacotherapy: Unraveling Mechanisms and Advancing Multi-Target Strategies in Alzheimer’s Disease. Pharmaceuticals. 2025;18(12):1797. doi:10.3390/ph18121797
BibTeX
@article{Stanciu2025,
author = {Stanciu, Gabriela-Dumitrita},
title = {Beyond Conventional Pharmacotherapy: Unraveling Mechanisms and Advancing Multi-Target Strategies in Alzheimer’s Disease},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {12},
pages = {1797},
doi = {10.3390/ph18121797}
}
EUVIMED